GlassScriptPhysician profile
Michele L Custer
NPI 1124582598
$581.09
in general payments reported to CMS, 2019-2025
12 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $401 · 2023: $18.58 · 2024: $33.27 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $133.89 | 2021 | |
| Scilex Pharmaceuticals INC. | $106.49 | 2021 | |
| Biodelivery Sciences International, INC. | $56.95 | 2021 | |
| Depuy Synthes Sales INC. | $51.11 | 2024-2025 | Orthovisc, Monovisc |
| Abbvie INC. | $50.40 | 2021 | |
| Ermi LLC | $45.87 | 2023-2025 | |
| Forte Bio-Pharma LLC | $37.92 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $33.43 | 2025 | |
| Pfizer INC. | $26.17 | 2025 | |
| Grt US Holding, INC. | $15.58 | 2021 | |
| Heraeus Medical, LLC. | $15.34 | 2025 | |
| Electronic Waveform Lab, INC. | $7.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Custer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.